Related Experiment Videos
[Glaucoma-screening with the Heidelberg Retina Tomograph II]
Péter Kóthy1, Péter Vargha, Gábor Holló
11. Universitäts-Augenklinik, Semmelweis-Universität Budapest, Hungary. kotpet@szem1.sote.hu
Klinische Monatsblatter Fur Augenheilkunde
|September 4, 2003
Summary
The Heidelberg Retina Tomograph II (HRT II) shows low sensitivity for glaucoma screening, making it unsuitable alone. However, HRT II may be valuable when used with other diagnostic tools for comprehensive eye care.
Area of Science:
- Ophthalmology
- Medical Imaging
- Glaucoma Diagnosis
Background:
- Glaucoma screening aims to detect the disease early to prevent vision loss.
- The Heidelberg Retina Tomograph II (HRT II) is a technology used for optic nerve head imaging.
Purpose of the Study:
- To evaluate the clinical usefulness of the HRT II for glaucoma screening.
- To compare HRT II classifications with established clinical diagnostic methods.
Main Methods:
- HRT II measurements were conducted on glaucomatous, normal, and glaucoma suspect eyes.
- HRT II classifications were compared against clinical examinations, perimetry, and GDx nerve fiber analysis.
Main Results:
- HRT II measurements were successful in 82.7% of cases.
- Diagnostic sensitivity was 60%, with specificity ranging from 88.8% to 100%.
- HRT II classification agreement with clinical, GDx, and visual field classifications was moderate (63.7%-65.4%).
Conclusions:
- The HRT II, with current software, is not suitable for standalone glaucoma screening due to low sensitivity.
- HRT II shows potential utility as an adjunct to existing diagnostic techniques in ophthalmology.